Manganese is a new hope in heart disease treatment

Credit: Unsplash+

Cardiovascular disease (CVD) is the leading cause of death worldwide, with atherosclerosis—a condition characterized by the buildup of plaques in the arteries—playing a significant role.

These plaques can rupture, leading to life-threatening events such as heart attacks and strokes. One of the major factors contributing to CVD is dyslipidemia, which is the presence of excessive “bad” lipids in the bloodstream.

This condition affects nearly half of all adults, making it a critical area of focus in the fight against heart disease.

Current treatments for dyslipidemia, including lipid-lowering drugs, are effective in stabilizing these dangerous plaques but are unable to completely eliminate them.

However, two recent studies have introduced a groundbreaking approach that could potentially reverse plaque buildup through intensive lipid reduction.

The Surprising Role of Manganese

Manganese is typically regarded as a trace element that plays supportive roles in various enzymatic reactions in the body.

However, these new studies have brought manganese into the spotlight as a key player in a novel therapy for reducing blood lipids and clearing atherosclerotic plaques.

In experiments with mice, researchers found that administering higher doses of manganese, even through dietary sources, significantly lowered blood lipid levels and effectively reduced existing arterial plaques.

This remarkable effect stems from manganese’s unexpected role in controlling how lipids are delivered into the bloodstream.

Lipids, such as cholesterol and triglycerides, are transported in the blood by particles known as lipoproteins. These lipoproteins are larger and more complex than other blood components, and their efficient transport is crucial for maintaining normal lipid levels.

The researchers discovered that lipoproteins rely on a cellular process involving a structure known as the coat protein complex II (COPII) to carry lipids through the bloodstream.

Manganese as a Regulator of Lipid Transport

The studies revealed that manganese ions have a direct impact on the COPII complex by enhancing its ability to condense, which is necessary for bulk lipid transport.

This regulation of the COPII complex by manganese is critical in maintaining the balance of lipid levels in the blood.

Interestingly, the effect of manganese on blood lipid levels follows a unique bell-shaped curve. This means that while manganese enhances COPII condensation up to a certain point, beyond that, it actually disrupts the lipid transport process.

This disruption can lead to a significant reduction in blood lipid levels, which in turn can help clear arterial plaques.

In the studies, this manganese-based therapy was shown to clear plaques in mice with CVD, offering a promising new approach to treating the disease.

A New Avenue for Heart Disease Treatment

Dr. Xiao Wang, one of the lead researchers involved in the studies, expressed excitement about the potential of manganese in preventing and treating cardiovascular disease.

The research team is eager to further explore the safety and effectiveness of this therapy and to develop more efficient methods for harnessing manganese’s unique signaling function.

Looking Forward

These groundbreaking studies suggest that manganese could be a powerful tool in combating cardiovascular disease by intensively lowering blood lipids and clearing atherosclerotic plaques.

While more research is needed to confirm these findings and assess the safety of manganese-based therapy in humans, this discovery offers a new and promising direction in the ongoing battle against the world’s leading cause of death.

For those concerned about heart health, it’s important to stay informed about new developments. Studies show that certain herbal supplements could harm your heart rhythm, while eating eggs may reduce the risk of heart disease.

Additionally, research has revealed new ways to prevent heart attacks and strokes, and some heart disease medications might even reduce the risk of COVID-19.

The findings on manganese and cardiovascular disease can be found in the journal Life Metabolism.

If you care about heart health, please read studies that vitamin K helps cut heart disease risk by a third, and a year of exercise reversed worrisome heart failure.

For more information about heart health, please see recent studies about supplements that could help prevent heart disease, stroke, and results showing this food ingredient may strongly increase heart disease death risk.

Copyright © 2024 Knowridge Science Report. All rights reserved.